Home > National Drug Code (NDC) > Atracurium Besylate

Atracurium Besylate - 25021-659-05 - (atracurium besylate)

Alphabetical Index


Drug Information of Atracurium Besylate

Product NDC: 25021-659
Proprietary Name: Atracurium Besylate
Non Proprietary Name: atracurium besylate
Active Ingredient(s): 10    mg/mL & nbsp;   atracurium besylate
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Atracurium Besylate

Product NDC: 25021-659
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA091488
Marketing Category: ANDA
Start Marketing Date: 20120501

Package Information of Atracurium Besylate

Package NDC: 25021-659-05
Package Description: 10 VIAL in 1 CARTON (25021-659-05) > 5 mL in 1 VIAL

NDC Information of Atracurium Besylate

NDC Code 25021-659-05
Proprietary Name Atracurium Besylate
Package Description 10 VIAL in 1 CARTON (25021-659-05) > 5 mL in 1 VIAL
Product NDC 25021-659
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name atracurium besylate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20120501
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name ATRACURIUM BESYLATE
Strength Number 10
Strength Unit mg/mL
Pharmaceutical Classes Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]

Complete Information of Atracurium Besylate


General Information